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ess: sdamato@qubisoft.Summary It is widely acknowledged that avoidance of allergens such as those
derived from foods, drugs, latex and stinging insects results in a complete
disappearance of symptoms. By contrast, although it has been clearly shown that
allergens are an important risk factor for the development of respiratory symptoms
and that several avoidance measures reduce allergen levels, whether this gives
clinical improvement in symptoms is debatable.
Many reasons could be invoked to justify this evident discrepancy. Apart from the
intrinsic methodological aspects (e.g. single or combined interventions measure,
population studied, severity of respiratory symptoms, outcomes, evaluated
parameters, etc.), it is important to outline that a successful approach requires
that the avoided allergen is the only and real factor responsible for symptoms, the
patient’s education and the use of a comprehensive protocol to reduce allergen
exposure. Other important factors include the involvement of the patient, the
relevance of other allergens/non-specific agents, and exposure to sensitizing agents
also outside patient’s home.
It is likely that the clinical phase of allergic airway disease and the degree of
bronchial (and also nasal) remodelling, in each individual, represent relevant factors
for the clinical outcome of allergen avoidance procedures. Since the management of
respiratory allergy is a complex strategy (including drugs, allergen avoidance,
immunological and educational interventions), it is difficult in real life to distinguish
the efficacy of a single intervention in comparison to the others. A combined
strategy is likely to produce better clinical results.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
7473335432; fax :+39 081 7473331.
it (G. D’Amato).
ARTICLE IN PRESS
G. Liccardi et al.1364ContentsIntroduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1364
Models for assessing the effects of aeroallergen avoidance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1365
The
’ ’
threshold level’’ for mite and pet allergens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1365
Mite and pet allergen carrying particles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1366
Aeroallergen avoidance during pregnancy and early life (primary prevention) . . . . . . . . . . . . . . . . . . . . . . 1366
The problem of bedding materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1366
New mattresses. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1367
Encasings and impermeable covers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1367
Synthetic and feather pillows/mattresses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1368
Washing and drying systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1368
Interventions on environmental air . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1369
Control of humidity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1369
Air filtering . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1369
Chemical agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1369
Vacuum cleaners . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1370
Other anti-mite interventions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1370
Special problems with pets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1370
General considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1370
The problem of the ubiquity of cat/dog allergens and possible prevention modalities . . . . . . . . . . . . . . 1371
Other modalities for removing cat allergens from indoor environments . . . . . . . . . . . . . . . . . . . . . . . 1371
Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1371
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1372Introduction
It is now quite clear that the development of
respiratory allergies depends on a complex inter-
action between genetic, maternal and environ-
mental factors. Among the latter ones, exposure
to allergens, endotoxins, indoor and outdoor air
pollution seem to be the more relevant. It is
also likely that changes induced by human acti-
vities in indoor and outdoor environments, as
well as the
’ ’
Westernized’’ lifestyle, play an
important role in increasing the prevalence of
atopic diseases in the general population.1 On the
other hand, it is generally accepted, with some
exceptions2,3 that atopy is a main risk factor for the
development of bronchial asthma, especially in
children.4
Certainly, the characteristics of modern indoor
environments (insulation of doors/windows, re-
duced natural ventilation, upholstered furniture,
central heating, etc.), at least in Western countries,
in addition to the current lifestyle (more time spent
indoors) increase the duration and intensity of
exposure to mites, pets and cockroach products5,6
as well as to indoor chemical agents. In this regard,
it has been clearly shown that exposure of sensitized
patients to allergens is a risk factor for development
of asthma and asthma exacerbations.7,8
A direct correlation between the exposure to
dust mite allergens and the development of allergic
sensitization is generally easy to demonstrate,especially in children, whereas in adults or in
previously sensitized subjects the relationship is
less clear, since asthma symptoms in each indivi-
dual may be induced by different doses of allergen
and even by non-specific agents.9 It is indeed
ascertained that atopic asthma is more severe in
sensitized patients, when they are exposed to high
levels of allergens.10–13 Different studies have also
suggested that the effect of the environment on
airways starts early. For instance, it has been shown
that maternal smoking in pregnancy has a signifi-
cant impact on long function in newborn.14
Similarly, allergen exposure during early pregnancy
was shown to affect the cellular proliferative
responses during late pregnancy.15
All the aforementioned observations, taken to-
gether, indicate that preventive or avoidance
measures (possibly taken already during pregnancy)
should be crucial. Allergen avoidance is highly
effective in selected conditions such as drug allergy,
hymenoptera venom hypersensitivity, food and latex
allergy. On the contrary, although experimental data
generally support the efficacy of allergen avoidance
strategies in respiratory allergy, their real outcome
is still controversial16 (Fig. 1).
This review will focus on recent advances in mite
and pet allergen avoidance strategies, starting
from the last months of pregnancy onwards. A
particular attention will be paid to the outcome
measures used, as well as to the objective evalua-
tion of cost/benefit ratio of these procedures.
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aeroallergen avoidance
Occupational asthma represents a very simple
model to verify the relationship between allergen
exposure and respiratory symptoms, as well as the
outcome of allergen withdrawal. In the majority of
studies it was clearly shown that workers comple-
tely recovered or significantly improved when
removed from their working environment.17–21
Avoidance trials performed at high altitudes,
where mites do not survive, provided important
lessons on the effectiveness of avoidance proce-
dures. Studies carried out in Misurina, Italy, and in
Davos, Switzerland (more than 1500m over the sea
level), confirmed the effects of a virtually mite-
free environment on clinical and laboratory indexes
in asthmatic children sensitized to mite allergens
(Table 1). Indeed, the observed clinical improve-
ments in those conditions could be also attributed
to the absence of other pro-inflammatory agents
such as air pollutants. The fact that children
relapsed after returning to sea level does not help
discriminating the real quantitative effect of
allergen avoidance.
The models of occupational allergy and mite-free
environments seem to support the effectiveness ofTable 1 Observed effects on clinical and laboratory par
Author Year References Outcomes
Boner et al. 1985 22 Exercise-indu
Boner et al. 1993 23 Serum marke
Van Velzen et al. 1996 24 Non-specific b
Peroni et al. 1994 25 Non-specific a
Piacentini et al. 1993 26 Antigen-provo
Piacentini et al. 1996 27 Sputum eosin
Piacentini et al 1998 28 Bronchial epi
Simon et al. 1994 29 T helper cell
Piacentini et al. 1999 30 Exaled nitric
Peroni et al. 2001 31 Residual volu
Grootendorst et al. 2001 32 Quality of life
Peroni et al. 2002 33 Residual volu
Allergen avoidance     Reduction of allergen exposure in 
 indoor environments.
?   ?
Long term
reduction of the risk of Clinical efficacy on respiratory
  developing allergic sensitisation       symptoms in real life. 
in newborn (primary prevention). 
Figure 1 Relationship between allergen avoidance pro-
cedures, allergen exposure and clinical outcomes.avoidance procedures, at least in particular condi-
tions. Nevertheless, in the last few years conflicting
opinions have came out. In 1998, the Cochrane
Collaboration published a meta-analysis of second-
ary mite allergen avoidance. The reviewers con-
cluded that
’ ’
current physical and chemical
methods aimed at reducing exposure to allergens
from house dust mites seem to be ineffective and
cannot be recommended as prophylactic treatment
for asthma patients sensitive to mites’’.34,35 On the
contrary, Platts-Mills et al. pointed out that
’ ’
the
real question posed by prevention strategies is not
whether allergen avoidance is good for allergic
patients with asthma but whether the changes that
have been consistently demonstrated in a sanator-
ium, hospital room or at high altitude can be
achieved in real homes’’.36
In this regard, a comparison among the different
studies of avoidance intervention in asthmatic
patients is virtually impossible to perform, due to
the large number of variables involved. Some of
these variables among studies include: heteroge-
neity of disease’s severity, confounding drug treat-
ments, multiple sensitization, concomitant use of
multiple avoidance procedures, considered out-
comes, allergen sampling methods and duration of
the studies.16The
’ ’
threshold level’’ for mite and pet
allergens
Different levels of mite and pet allergens inducing
sensitization and/or asthma exacerbations have
been suggested.37 However, these threshold
amounts of allergen may greatly vary, according
to the individual degree of bronchial responsive-
ness and the possible effect of non-specificameters in mite sensitised children at high altitude.
ced bronchial reactivity, medication intake
rs of eosinophil activation
ronchial hyperreactivity (BHR)
nd specific BHR, total and specific IgE
ked basophil histamine release and specific IgE
ophilia
thelial shedding
activation
oxide
me and sputum eosinophils
, BHR, urinary eosinophil protein X and leukotriene E
me and exhaled nitric oxide
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sensitized patients and the variability over time
of allergen exposure, it is difficult to calculate a
fixed and standard environmental concentration of
allergen (possibly expressed as mg/g of dust or
mg/m2), as a threshold valid for all individuals.38,39
Previous trials have demonstrated that a concen-
tration of 2 mg Der p 1/g dust is the threshold for
inducing sensitization, whereas 10 mg/g represents
the threshold for triggering asthma attacks in mite
allergic individuals.40 Based on these results it was
argued that an exposure constantly below 2 mg/g of
dust would have provided measurable clinical
results.41 Nevertheless, other authors have sug-
gested that the threshold concentration of Der p 1
inducing airway sensitization is inferior, because
highly susceptible children may become sensitized
at concentrations 10–100 times lower than 2 mg/
g.42,43 In patients sensitized to cat, the threshold
concentration of Fel d 1 inducing sensitization and
triggering bronchial obstruction is lower: 1 and
8mg/g of dust, respectively.44 Also in this latter case
there are conflicting opinions. The amount of cat
allergens in the dust may not reflect the real global
environmental exposure, since Fel d 1 is largely
present also as airborne particles and not only in the
dust. Probably, the threshold level should be better
determined by airborne samplers.45Mite and pet allergen carrying particles
The determination of sources and aerodynamic
characteristics of allergen carrying particles is an
important tool for designing mite and pet allergen
avoidance strategies.46 Group 1/group 2 mite
allergens are carried by relatively large particles
(410 mm diameter), which can be detected in the
air of indoor environments only after a strong
disturbance, whereas in quiet conditions, these
allergens can be found only in reservoirs.47 On the
contrary, allergens derived from domestic animals
such as cat (Fel d 1) and dog (Can f 1) are carried
both by large particles of about 10 mm diameter
(75%) and by smaller particles of o5 mm diameter
(approximately 25%).48,49 After a minimal air
disturbance, these small particles readily become
airborne and so remain for long periods. The
airborne dispersed allergens can trigger respiratory
symptoms in sensitized patients within few min-
utes. This is the reason why air filtration devices
may be useful to reduce the amount of
pet allergens in the air47 by approximately
two- to four-fold.50 Of course, these devices are
not effective in removing allergens from their
reservoirs.Aeroallergen avoidance during
pregnancy and early life (primary
prevention)
In the last few years an increasing interest has been
devoted to the perinatal period and early infancy as
critical time intervals for the subsequent develop-
ment of respiratory allergy. This has envisaged the
possible role of reducing exposure to aeroallergens
in these periods to prevent the development of
allergic sensitization and bronchial asthma. Indeed,
apart from the exposure to tobacco smoke, the
scientific evidence for the effects of environmental
factors on the development of allergic sensitization
and asthma is still controversial.51 Effective primary
preventive methods have been difficult to assess,
and those currently suggested are questionable.52
The optimal approach to study the effects of
primary prevention should be a randomized inter-
vention study, starting in pregnancy and involving
many high-risk families. This type of study is
complex, time-consuming and expensive, but crucial
to establish the efficacy of such approach to reduce
the prevalence of respiratory allergies. In the last
few years, several birth cohort studies of inhalant
allergens avoidance (also associated to food aller-
gens avoidance) have been performed. As summar-
ized in Table 2, environmental interventions were
generally able to significantly reduce the allergen
load (especially those of dust mites). On the
contrary, although preliminary results are encoura-
ging, no final conclusion on the clinical effect of
allergen avoidance in reducing the risk of developing
respiratory allergy can be drawn. It is not known how
long these intervention measures should be contin-
ued, and how long the children should be followed
up, but it is likely that a very long time would be
necessary to obtain incontrovertible answers.
The environmental interventions to reduce the
levels of indoor allergens, especially those pro-
duced by mites and pets, used in the primary
prevention studies are the same that were recom-
mended in secondary and tertiary prevention (see
after). It is important to outline the role of the
compliance of the parents receiving advice to
reduce exposure to mite and pet allergens and to
avoid passive smoking.60,66The problem of bedding materials
Beds are the most important source of mite
allergens. Dust mites can find a large amount of
food in terms of human epithelial derivatives and
thus they optimally proliferate in beds. In addition,
sleeping patients are exposed to mite allergens for
ARTICLE IN PRESS
Table 2 Environmental allergen control and/or clinical outcomes in primary prevention studies.
Author Year References Intervention Reduction of
allergen amount
Clinical efficacy
Arshad et al. 1992 53 Dietary+Environmental + +
Hide et al. 1996 54 Dietary+Environmental + +
Arshad et al. 1993 55 Dietary+Environmental + +
Mihrshahi et al. 2003 56 Dietary+Environmental + +/
Chan-Yeung et al. 2000 57 Dietary+Environmental + +
Halmerbauer et al. 2004 58 Dietary+Environmental NA +
Backer et al. 2004 59 Dietary+Environmental + +
Schonberger et al. 2004 60 Dietary+Environmental + NA
Custovic et al. 2000 61 Environmental + NA
Custovic et al. 2001 62 Environmental + +
Simpson et al. 2003 63 Environmental + NA
Koopman et al. 2002 64 Environmental + +/
Wickman et al. 2003 51 Environmental + +
Mihrshahi et al. 2003 65 Environmental + NA
NA ¼ not applicable.
New insights in allergen avoidance measures for mite and pet sensitized patients. 1367hours. Based on this background, the reduction of
mite allergen exposure in the bedroom and bed is
generally considered a primary target for avoid-
ance measures.New mattresses
In clinical practice, it is often suggested to buy a
new mattress for newborn babies. This recommen-
dation relies on the assumption that new mat-
tresses are free of allergen. A recent study by de
Boer et al.67 performed on newly bought mattresses
demonstrated that only 15 of the 90 mattresses
contained no detectable amount of the four tested
allergens (Der p 1, Der f 1, Fel d 1 and Can f 1). The
study showed that also new mattresses, wrapped in
plastic, may contain a substantial amount of
allergens, and does not substantiate the clinical-
based recommendation for newborns. A regular
vacuuming of the new mattresses is also suggested
to ensure the removal of mite allergens. However,
this type of treatment (at variance with the use of
chemical agents) is very difficult to perform
because the thickness of the mattresses does not
allow an effective intervention. Also, new mat-
tresses are rapidly infested by dust mites under
favourable climate and housing conditions such as
dampness.68,69Encasings and impermeable covers
It is usually accepted that the most effective
avoidance measure is the use of mite-impermeable
covers for the mattresses, pillows and duvets70 inassociation with washing bedding materials at hot
temperature.71 These procedures are commonly
used in clinical practice. Nevertheless, looking at
the literature, there are conflicting results on the
efficacy of physical barriers. Many reasons can be
addressed to explain these differences (combined
use of other anti-mite procedures, study design,
study population and outcomes). Also, the type of
material used for encasing (plastic sheet, polyur-
ethane, non-woven tissues, microfibre covers) re-
presents an important variable. In this regard,
Mahakittikun et al.72 performed a detailed labora-
tory assessment (heat escape method, Siriraj
chamber method, stereomicroscopy, scanning elec-
tron microscopy and enzyme-linked immunosorbent
assay) to establish the efficiency of encasing
materials against house dust mites and their
allergens. Only encasings with a pore size of
2–10mm (mean 6mm), such as tightly woven micro-
fiber covers, could completely prevent the passage
of mites and mite-derived materials still retaining a
good level of comfort and air permeability.73
However, from a practical point of view, it is
important to clearly distinguish between the two
efficacy outcomes in real life.74 The effects of
physical barriers on allergen amount (allergen
content, number of mites, proliferation, etc) are
easy to verify and quantify with laboratory techni-
ques, but the clinical effects (symptoms) often do
not reflect what is observed under controlled
conditions.74 As shown in Table 3, encasings are
clearly able to reduce the amount of mite aller-
gens. However, the use of anti-allergic mattress
covers, as a single intervention measure, does not
result in significant clinical benefit in adult asthma.
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Table 3 recent studies (1999–2004) on the effects of encasings in respiratory allergy ( tertiary prevention).
Author Year References Reduction of
allergen amount
Clinical efficacy
Cloosterman et al. 1999 75 + 
Rijssenbeek et al. 2002 76 + 
Sheikh et al. 2003 77 NA 
Koopman et al. 2002 64 + 
Rijssenbeek et al. 2002 78 + + Nasal
 Bronchial
Arshad et al . 2002 79 NA +
Halken et al. 2003 80 + + Reduced inhaled steroids
Brunekreef et al. 2002 81 + 
Woodcook et al. 2003 82 + 
Terrehorst et al. 2003 83 +  Nasal
Luczynska et al. 2003 84 + 
G. Liccardi et al.1368Some previous 30,43,85 and a recent86,87 meta-
analyses have confirmed that bedding encasement
might be an effective avoidance procedure in some
patients with asthma, but data from clinical trials
suggested that the clinical effect is marginal.Synthetic and feather pillows/mattresses
Feathers in pillows and bedding have long been
considered as an ideal breeding ground for dust
mites and, consequently, a potential source of mite
allergen exposure. Moreover, feather itself has
been previously considered as an allergen. There-
fore, it has become common to advice allergic
peoples to avoid the use of feather bedding, but
the evidence for such recommendation is not
strong.88–90 In this regard, recent studies have
demonstrated that feathers are not allergenic, and
the positive skin prick test responses are likely due
to mite contamination.91,92 Moreover, modern
feather bedding manufacturing procedure involve
washing and hot drying that are able to kill mites
and to denature group 1 mite allergens.93
Recent cross-sectional studies have shown that
synthetic bedding is significantly associated with
several respiratory diseases. Synthetic pillows
contain higher concentrations of several types of
allergens (mite and pets) compared with feather
pillows.94–96 Moreover, the risk of finding mite
faeces was found four-fold higher in foam com-
pared to spring mattresses and eight times higher
for the foam mattresses without cover.97 Besides
the finding that synthetic materials contain higher
amounts of different indoor allergens, some hy-
potheses have been suggested to explain the
association between synthetic bedding and devel-
opment of respiratory allergy: release of organicvolatile compounds, intrinsic allergenicity of the
materials, the covers of feather pillows are more
impermeable to mite allergens (tightly woven
microfiber covers),etc.98 In the light of these
controversial findings, there is a weak scientific
basis for recommending non-feather or synthetic
bedding in our mite sensitized patients or in infants
of highly atopic parents. Further longitudinal
(randomized and controlled) studies are required
for a conclusive assessment of this question.89,90Washing and drying systems
All bedding and covers should be washed at a
temperature of at least 55 1C that is ideal to kill
mites. However, higher temperatures (120–140 1C)
are required to denaturate Der p 1 and Der p 2, as
well as the group 1 and 2 allergens of Dermato-
phagoides farinae.99
Commercial, and likely also domestic, hot-
laundering results in near-complete removal of
mite allergen from bedding. However, a wash cycle
where temperatures above 55 1C are sustained for
at least 12min (or above 60 1C for 8min) is
sufficient to eliminate 480% of mites.100 Consider-
able variation exists in the ability of both domestic
and commercial machines to reach such tempera-
tures, and this ability should be confirmed before
recommending hot-laundering as a method of
eliminating house dust mites from textiles.100
Exclusive washing in cool water may remove mite
allergens, but does not kill mites. It has also been
demonstrated that live mites can be transferred
from mite-infested to mite-free items during
washing.101
The association of soluble form of benzyl
benzoate (0.03%) or some essential oils (e.g.
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activity.71,99,102 Recent studies have shown that
washing clothing and bedding with detergents or
detergents plus bleach in cold or warm water are
able to remove most (98%) mite and cat allergens,
but repeated washing is required to further reduce
mite levels. Dry cleaning may also be useful either
to kill mites or to remove allergens from blankets,
although it is less effective than washing in hot
water.101,103,104Interventions on environmental air
Control of humidity
The control of indoor humidity (o45%), is an
important measure to reduce mite growth. How-
ever, evidence that a reduction in indoor humidity
induces a concomitant reduction in humidity in
mite microhabitats is still lacking.47 An increased
natural ventilation rate may be useful in those
geographic areas in which the outdoor air is
sufficiently dry. Some studies have suggested that
dehumidifiers in the basement and air conditioners
may play an important role in controlling mite
growth in temperate climate. Nevertheless, the
outcomes of such measure are marginal, and their
clinical efficacy is too controversial to make
recommendations.105,106
Air filtering
The idea of filtering the air we breathe in order to
remove allergens is theoretically attractive. How-
ever, several technical problems still exist espe-
cially concerning the filters used. The main
requirements for an optimal air filtering system
are: low resistance to airflow, cleaning efficiency,
low or no need for maintenance interventions and
long life. The most efficient filters are HEPA filters.
These are defined by their filtration efficiencyTable 4 Effects of air cleaners in mite and pet allergy.
Author Year Reference Mite allerge
Van der Heide et al. 1997 107 
Green et al. 1999 108 NA
Warburton et al. 1994 109 NA
Van der Heide et al. 1999 110 NA
Wood et al. 1998 50 NA
Gore et al. 2003 111 NA
Francis et al. 2003 112 NA
NA ¼ not applicable.(99.97% of all airborne particles of 0.3 mm are be
removed from the air passing through them).
Although both allergic and non-allergic indivi-
duals may achieve symptomatic benefit from
removing irritant particles such as tobacco smoke
from the air, filtration units do not reduce the
levels of mite allergens in indoor environments. In
fact, the greatest amount of these allergens
remains in settled dust. On the contrary, a long-
term use of HEPA-equipped air cleaners may be
useful to remove large amounts of airborne
particles carrying cat and dog allergens. Also in
this case, conflicting opinions still exist on the
clinical efficacy of air filtration units, also con-
sidering their high cost (Table 4).Chemical agents
Over the last 30 years, a variety of chemicals has
been tested for their ability to kill mites in culture
(Table 5). It is important to outline that mites are
not insects and that many excellent insecticides do
not kill mites at the concentration that can be used
in houses. Although many agents demonstrate an
optimal in vitro activity, their efficacy in real life
depends upon other factors such as method and
time of application, type of formulation (liquid,
moist powder, foam, spray, etc), local conditions
(e.g. type and thickness of carpets) and effective-
ness of vacuum cleaning in removing dead mites
and their products from reservoirs after their use.
The results of clinical studies of these products
are controversial. In fact, some authors demon-
strated positive benefits in controlling mite popula-
tions and, consequently, clinical symptoms in
allergic patients,114,115 but other studies failed to
confirm these positive effects.116,117
Most studies of acaricides or allergen-denaturing
agents suggest that repeated applications (every
2–3 months) are needed to prevent mite re-
infestation. The need for a long-term use of thesen removal Pet allergen removal Clinical results
+ 
+ NA
NA 
+ +
+ 
+ +/
 +/
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especially to children or domestic animals.
Very few studies have evaluated the role of
chemical agents in reducing the degree of exposure
to pet allergens. Recently, Matsui et al.118 demon-
strated that low concentrations of sodium hypo-
chlorite (NaOCl), the active ingredient in household
bleach, modifies rFel d 1 resulting in loss of
immunogenecity and attenuation of biologic activ-
ity, as measured by its ability to stimulate basophil
histamine release.Vacuum cleaners
Regular and intensive vacuum cleaning is consid-
ered useful to reduce the amount of mite (or pet)
allergens in the reservoir, but the simultaneous use
of other measures is mandatory for effective
elimination of allergens in carpets and furnish-
ings.119
The major problem with vacuum cleaners is that,
independent of the potency of the apparatus, they
cannot completely remove live mites from surfaces
(e.g. carpets) and they even allow debris to
accumulate. There are two critical aspects in
carpet cleaning: first, whether the cleaner can
remove dust from the carpet and, second, how
much allergen/dust becomes airborne while the
cleaner is in use.
The new exhaust filtration systems, e.g. HEPA
filters and double-thickness bags, electrostatic
filtration system,120 or polyethylene filters that
can be easy washed in water121 seem to be efficient
enough to avoid an increase in the indoor airborne
levels of mite allergens.
Gore et al.122 demonstrated a three- to five-fold
increase in personal cat allergen exposure while
using both high-efficiency new vacuum cleanersTable 5 Anti-mite agents.
Agent Mechanism
Benzyl benzoate,
pyrethroids, disodium
octaborate113
Direct killing of mites
Natamycin Reduces mite
population via killing
mold spores
Tannic acid Denaturation of mite
allergens
Liquid nitrogen Direct killing of mites
by freezing
Common salt Killing by dehydrationand older vacuum cleaners including a water-
activated device. The evaluation of personal
exposure to allergen was carried out using nasal
air samplers123 for 15min. This finding is probably
due to high concentrations of cat allergens in the
dust reservoirs (such as carpets, soft furnishing,
mattresses and also wall surfaces) of houses
containing a cat.Other anti-mite interventions
Various empiric approaches have been used to
reduce mite allergens: freezing of household
articles such as soft toys in a domestic freezer for
24 h,38 the use of an electric heating carpet in the
bedroom,124 the use of an autoclave to heat
rugs.125 and hot tumble drying.126 For those
measures the experimental evidences are few and
weak.
Recently, Goodman and Huges127 studied the
effect of
’ ’
corona discharge’’ on Der p 1. Their
data provide evidence that corona products may be
a powerful method for destroying Der p 1 allergens,
independent of the presence of the oxidizing
corona product ozone.Special problems with pets
General considerations
Conflicting opinions still exist in the literature
about the efficacy of prevention strategies to avoid
exposure to the allergens of domestic animals
particularly cats and dogs. Although the removal
of these furred pets from domestic environment is
usually considered the first-line measure from a
clinical point of view, there is no documented
report on the efficacy of cat/dog removal in
reducing clinical symptoms in sensitized patients.
Many pet sensitized patients, particularly chil-
dren, refuse to give up their animals.128 Other
patients, despite the obvious source of their
symptoms, are often unwilling to recognize the
correlation between pet-ownership and clinical
symptoms and consequently refuse to remove their
cats.129 Finally, it has been shown that parents of
cat allergic children (about 55%) deny that their
child’s symptoms are worsened by the pet’s
presence.130 These are some of the reasons why,
in the majority of cases, the eviction of pet
allergens must be carried out with the animal
standing at home.
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allergens and possible prevention modalities
Even when furred pets (in particular cats) have
been removed from the environment, it is unlikely
that the exposure to allergens is completely
abolished. In fact, there is a large body of evidence
suggesting that cat allergen may be found in many
indoor environments where cats have been re-
moved from long periods.
Obviously, an intensive avoidance procedure
(replacing furniture and blankets, vigorous vacuum
cleaning, using air filtration systems) carried out
after cat/dog removal, can significantly reduce the
levels of Fel d 1 and Can f 1. However, it is unlikely
that cat allergens are completely removed from a
contaminated indoor environment. Many studies
have shown that the majority of domestic environ-
ments (and public places) where a cat/dog
has been never kept may contain significant
amounts of Fel d 1 and Can f 1. In addition, some
clinical data have proven that even low levels
of cat allergens (found in indoor environments
without cats) are able to induce respiratory
symptoms in highly sensitive patients. Several
authors have consistently demonstrated that
the clothes of cat owners represent the main
source for the dispersal of cat allergens in cat-
free environments.131 We have recently shown that
an indirect modality of allergic sensitization is
possible also for other furry animals such as
rabbit.132
These considerations suggest that the removal of
cat proteins from the clothes of cat owners may be
an important approach for the prevention of
dispersal of these allergens in animal-free environ-
ments.
Based on these premises, we designed a project
to evaluate the efficacy of different methods of
cleaning (with and without the use of water)
materials passively contaminated by contact with
cats. We demonstrated that Fel d 1 can be
completely removed from contaminated cotton
webs by simply washing them in water.133 Also,
we recently evaluated the efficacy of commercial
dry cleaning that is commonly used in industrialized
countries, using the same study design and a
different type of material (wool). Dry cleaning
was able to remove large amounts of Fel d 1 from
contaminated wool fabrics but did not completely
abolish cat allergen contamination.134 Further,
Fel d 1 contamination of three control (previously
non-exposed) wool rectangles after dry clean-
ing suggested that cat allergens can be transferred
from other clothes during the dry cleaning
process.134Another recent study by Karlsson et al.135 carried
out in Swedish schools confirmed the role of
clothing as reservoir of cat allergen. They demon-
strated that the use of special school clothing (or
ban pet ownership) were able to induce four- to six-
fold lower airborne cat allergen levels in interven-
tion classes compared with control classes.
Other modalities for removing cat allergens
from indoor environments
It was suggested that washing domestic animals can
be an efficient strategy to remove allergens from
the body surface.136 Unfortunately, the amount of
pet allergens rapidly increases after washing and
return to previous level within few days. Therefore,
in order to achieve a satisfactory reduction of the
allergen level, the dog should be washed one, or
better two times a week.137 It is important to
remember that those frequent washing are not
practically feasible because they induce serious
dangerous effects on the fur by altering the lipidyc
film.
The aerodynamic properties of cat/dog allergens
justify the use of air filtration systems in indoor
environments containing these pets.50,138,139 The
air cleaners or filters remove significant amounts of
airborne Fel d 1/Can f 1 which represent the main
risk factor for inducing clinical symptoms in cat/
dog sensitized patients.
The use of a common furniture polish on either
the dusty surfaces and the cleaning cloth during
dusting was demonstrated useful in reducing both
dust and cat allergens (Der p 1 and Fel d 1)
dispersal.140 Fel d 1 allergen can be successfully
removed from hard floors by using electrostatic
cloth sweepers, which are now easy to find.141
However, a recent study demonstrated that the
common recommended intervention measures
(cleaning all internal surfaces, removal of texiles,
use of encasings, etc.) did not reduce the amounts
of airborne cat allergen.142Concluding remarks
It is widely acknowledged that avoidance of
allergens such as those derived from foods, drugs,
latex and stinging insects results in a complete
disappearance of symptoms. By contrast, although
it has been clearly shown that allergens are an
important risk factor for the development of
respiratory symptoms and that several avoidance
measures reduce allergen levels, whether this gives
clinical improvement in symptoms is debatable.
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evident discrepancy. Apart from the intrinsic
methodological aspects (e.g. single or combined
interventions measure, population, evaluated para-
meters, etc.), it is important to outline that a
successful approach requires that the avoided
allergen is the only and real factor responsible for
symptoms, the patient’s education and the use of a
comprehensive protocol to reduce allergen expo-
sure.36,143–147 Other important factors include the
involvement of the patient, the relevance of other
allergens, and exposure to sensitizing agents also
outside patient’s home.148
In our opinion, the clinical phase of allergic
airway disease and the degree of bronchial (and
also nasal) remodelling, in each individual, repre-
sent relevant factors for the clinical success of
allergen avoidance interventions. Since the man-
agement of respiratory allergy is a complex
strategy (including drugs, prevention, immunologi-
cal and educational interventions), it is difficult in
real life to distinguish the efficacy of a single
intervention in comparison to the others. A
combined strategy is likely to produce better
clinical results.149References
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